Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice

Journal of Virology

Volumn 70, Issue 3, 1996, Pages 1729-1737

  Kariuki Njenga, M ^a,b   Pavelko, Kevin D ^a   Baisch, Jeanine ^a,d   Lin, Xiaoqi ^a,b   David, Chella ^a   Leibowitz, Julian ^c   Rodriguez, Moses ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d Gene Screen   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENTARY DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE ANTIGEN; VIRUS RNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC DISEASE; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DEMYELINATING DISEASE; GENE DISRUPTION; HUMORAL IMMUNITY; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PATHOGENESIS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL;

EID: 9044227264     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.3.1729-1737.1996     Document Type: Article

References (46)

1. Aubert, C., M. Chamorro, and M. Brahic. 1987. Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb. Pathog. 3:319-326.
2. Bender, B. S., T. Croghan, L. Zhang, and P. A. Small, Jr. 1992. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J. Exp. Med. 175:1143-1145.
3. Cash, E. A., A. Bandeira, S. Chirinian, and M. Brahic. 1989. Characterization of B lymphocytes present in the demyelinating lesions induced by Theiler's virus. J. Immunol. 143:984-988.
4. Clatch, R. J., R. W. Melvold, S. D. Miller, and H. L. Lipton. 1985. Theiler's murine encephalomyelitis virus (TMEV) induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV-specific delayed-type hypersensitivity. J. Immunol. 135:1408-1414.
5. Clatch, R. J., S. D. Miller, R. Metzner, M. C. Dal Canto, and H. L. Lipton. 1990. Monocyte/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 176:244-254.
6. Cosgrove, D., D. Gray, A. Diericb, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell 66:1051-1066
7. Doherry, P. C. 1993. Virus infections in mice with targeted gene disruptions. Curr. Opin. Immunol. 5:479-183.
8. Doherty, P. C., S. Hou. and P. Southern. 1993. Lymphocytic choriomeningitis virus induces a chronic wasting disease in mice lacking class I MHC glyco-protems. J. Neuroimmunol. 46:31-17.
9. Eichelberger, M., W. Allan, M. Zijlstra, R. Jaenisch, and P. C. Doherry. 1991. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J. Exp Med. 174:875-880.
10. Fiette, L., C. Aubert, M. Brahic, and C. P. Rossi, 1993. Theiler's virus infection of β2-microglobulin-deficient mice. J. Virol. 67:589-592.
11. Fiette, L., C. Aubert, U. Muller, S. Huang, M. Aguet. M. Brahic, and J. F. Bureau. 1995. Theiler's virus infection of 129SV mice that lack the Interferon alpha/beta or Interferon gamma receptors. J. Exp. Med. 181:2069-2076.
12. Friedman, A., G. Frankel, Y. Lorch, and L. Steinman. 1987. Monoclonal antiI-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice' critical importance of tuning of treatment. J. Virol. 61:898-903.
13. Fujinami, R. S., A. Rosenthal, P. W. Lampert, A. Zurbriggen, and M. Yamada. 1989. Survival of athymic (nu/nu) mice after Theiter's mutine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody J. Virol 63:2081-2087.
14. Hou, S., P. C. Doherty, M. Zijlstra, R. Jaenisch, and J. M. Kafz. 1992. Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells. J. Immunol. 149:1319-1325.
15. Hou, S., L. Hyland, and P. C. Doherty. 1995. Host response' to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins J. Virol. 69:1429-1434.
16. Kaufmann, S. H. E. 1994 Bacterial and protozoal infections in genetically disrupted mice. Curr. Opin. Immunol. 6:518-525.
17. Lampert, P. 1967. Electron microscopic studies on ordinary and hyperacute experimental allergic encephatomyelitis. Acta Neuropathol. 9:99-126.
18. Laufer, T. M., M. G. von Herrath, M. J. Grusby, M. B. A. Oldtstone, and L. H. Glimcher. 1993. Autoimmune diabetes can be induced in iransgenic major histocompatibility complex class II-deficient mice. J. Exp. Med 178:589-596
19. Lin, X., R. L. Thiemann, L. R. Pease, and M. Rodriguez. 1995. VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cylotoxic lymphocytes in the central nervous system of B10 mice. Virology 214:91-99
20. Lipton, H. L. 1975. Theiler's virus infection in mice: an unusual biphasic disease leading to demyelination. Infect. Immun 11:1147-1155.
21. Lipton, H. L. 1978. Central nervous system immunity in mice infected with Theiler's virus. 1 Local neutralizing antibody response. J. Infect. Dis 137:145-151
22. Lipton, H. L., and M. C. Dal Canto. 1976. Theiler's virus-induced demyelination. prevention by immunosuppression. Science 192:62-64
23. Ohara, Y., S. Stein, J. Fu, L. Stillman, L. Klaman. and R. P. Roos. 1988 Molecular cloning and sequence determination of DA strain of Theiler's murine cncephalomyelitis viruses Virology 164:245-255.
24. Patick, A. K., E. L. Oleszak, J. L. Leibowitz, and M. Rodriguez. 1990. Persistent infection of a ghoma cell line generates a Theiler's virus variant which fails to induce demyelinating disease in SJL/J mice. J. Gen. Virol 71:2123-2132.
25. Paya, C. V., P. J. Leibson, A. K. Patick, and M. Rodriguez. 1990 Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha. Int. Immunol. 2:909-913.
26. Pierce, M., and M. Rodriguez. 1989. Enchrome stain for mycim on osmicated tissue embedded in glycol methacrylate plastic. J. Histotechnol. 12:35-36
27. Prayoonwiwat, N., and M. Rodriguez. 1993 The potential for oligodendrocyte proliferation during demyelinating disease. J Neuropathol Exp. Neurol. 52:55-62
28. Pullen, L. C., S. D. Miller, M. C. Dal Canto, and B. S. Kim. 1993 Class I-deficient resistant mice intracerebrally inoculated with Theilei's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J Immunol. 23:2257-2293.
29. Rahemtulla, A., T. M. Kündig, A. Narendran, M. F. Baehman. M. Julius. C. J. Paige, P. S. Ohashi, R. F. Zinkernagel, and T. W. Mak. 1994 Class II major histocompatibility complex-restricted T cell function in CD4-deficient mice. Eur. J. Immunol. 24:2213-2218.
30. Rodriguez, M. 1985. Virus induced demyelination in mice: "dying back" of oligodendrocytes. Mayo Clin. Proc. 60:433-436.
31. 2-microglobulin. J Immunol 151:266-276.
32. Rodriguez, M., J. J. Kenny, R. L. Thiemann, and G. E. Woloschak. 1990. Theiler s virus-induced demyelination in mice immunosuppressed with antiIgM and in mice expressing the xid gene. Microb. Pathog. 8:23-35.
33. Rodriguez. M., W. P. Lafuse, J. L. Leibowitz, and C. S. David. 1986. Partial suppression of Theiler's virus-induced demyelination in vivo by admimstration of monoclonal antibodies to immune-response gene products (Ia antigens). Neurology 30:964-970
34. Rodriguez, M., J. L. Leibowitz, and P. W. Lampert. 1983. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis Aim Neurol 13:426-432.
35. Rodriguez, M., J. L. Leibowitz, H. C. Powell, and P. W. Lampert. 1983 Neonatal infection with the Daniel strain of Theuer's murine encephalomyelitis virus. Lab. Invest 49:672-678
36. Rodriguez, M., and M. Lindsley. 1992. Immunosuppression promotes central nervous system remyelination in chronic virus-induced demyelinating disease. Neurology 42:348-357.
37. Rodriguez, M., M. D. Lindsley, and M. L. Pierce. 1991. Role of T cell resistance to Theiler's virus infection. Microb. Pathog. 11:269-281.
38. Rodriguez, M-, E. Oleszak, and J. Leibowitz. 1987. Theiler s murine enceph alomyelins. a model of demyelination and persistence of virus. Crit. Rev. Immunol 7:325-365.
39. Rodriguez, M., K. Pavelko, and R. L. Coffman. 1995. Gamma Interferon is critical for resistance to Theiler's virus-induced demyelination. J. Virol, 69:7286-7290.
40. Rodriguez, M., K. D. Pavelko, C. W. McKinney, and J. L. Leibowitz. 1994. Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J. Immunol 153:3811-3821.
41. Rodriguez, M., and J. Quddus. 1986. Effect of cyclosporin A, silica quartz dust and macrophage protease inhibitors on virus-induced demyelination. J Neuroimmunol. 13:159-174.
42. Rodriguez, M., and S. Sriram. 1988. Successful therapy of Theiler's virus-induced demyetination (DA strain) with monoclonal anti-lyt-2 antibody. J. Immunol. 140:2950-2955.
43. Roos, R. P., S. Firestone, R. Wollman, D. Variakojis, and B. G. W. Arnason. 1982 The effect of short term and chronic immunosuppression on Theiler's virus demyelination. J. Neuroimmunol. 2:223-234.
44. 2-Microglobulin, CD8+ T cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses Proc. Natl. Acad Sci. USA 89:6070-6074.
45. b gene. J. Immunol. 155:2955-2959.
46. Welsh, C. J. R., P. Tonks, A. A. Nash, and W. F. Blakemore. 1987. The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J. Gen. Virol 68:1659-1667